Schedule 13G ownership disclosure
aTyr Pharma Inc
COMMON STOCK · CUSIP: 002120202
Event date: 2026-10-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Federated Hermes, Inc.
Shares: 0.00 · Class: 0%
- Voting Shares Irrevocable Trust
Shares: 0.00 · Class: 0%
- Thomas R. Donahue
Shares: 0.00 · Class: 0%
- Ann C. Donahue
Shares: 0.00 · Class: 0%
- J. Christopher Donahue
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001623632-26-001648
- Form type
- SCHEDULE 13G/A
- Filer
- aTYR PHARMA INC
- CIK
- CIK 1339970
- Filed
- Nov 04, 2026
- Reporting period
- Oct 31, 2026
- Description
- Schedule 13G beneficial ownership